-
Mashup Score: 5PAX LC — Hugo Health Kindred - 1 year(s) ago
We’ve joined the race to find treatments. Kindred is working with Yale scientists to help speed research. Join Kindred now to enroll in PAX LC. This trial is limited to 100 people. The first 100 people who qualify will be invited to enroll.The PAX LC Clinical Trial is rapidly recruiting from the Kindred network. If you live in Connecticut, New York or Florida, were healthy prior to contracting…
Source: Hugo Health KindredCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3
Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide
Source: Yale School of MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
Ending this thread with a great description of our #PaxLCTrial by @IzzyBackman. This trial is decentralized, patient-centric, and intended to uncover biological features associated with symptom improvement with Paxlovid. (end) 🙏🏼 https://t.co/qiTjQqkts2
-
-
Mashup Score: 115PAX LC — Hugo Health Kindred - 1 year(s) ago
We’ve joined the race to find treatments. Kindred is working with Yale scientists to help speed research. Join Kindred now to enroll in PAX LC. This trial is limited to 100 people. The first 100 people who qualify will be invited to enroll.The PAX LC Clinical Trial is rapidly recruiting from the Kindred network. If you live in Connecticut, New York or Florida, were healthy prior to contracting…
Source: Hugo Health KindredCategories: Healthcare Professionals, Latest HeadlinesTweet-
We are now enrolling in the #PaxLCTrial; randomizing people with #longCOVID to 15 days of Paxlovid (nirmatrelvir/ritonavir) or placebo (placebo/ritonavir). Currently people in CT, NY, and FL can enroll. Hope to expand to other states soon. For more info 👉🏼 https://t.co/5yCM3TLKnM https://t.co/UQQutXmWpG
-
-
Mashup Score: 90
A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults With Long COVID. – Full Text View.
Source: clinicaltrials.govCategories: Cardiologists, Latest HeadlinesTweet-
Introducing the @Yale #PaxLCTrial, a research study that is digital, decentralized, and participant-centric; testing whether Paxlovid can improve health for patients living with #LongCovid. @YaleMed @YaleCII #YaleCORE @PutrinoLab @WesElyMD @VirusesImmunity https://t.co/arFocSsWIV https://t.co/pfLGpfdb25
-
Very excited that our PaxLC clinical trial on #longCOVID patients is now open, led by @hmkyale! This is a phase 2, 1:1 randomized, double-blind, placebo-controlled research study in 100 non-hospitalized highly symptomatic long COVID. (1/) https://t.co/hga9nt8EWv
-
-
Mashup Score: 0Hugo Health Kindred - 1 year(s) ago
Kindred is a growing health network for anyone affected by COVID. Collaborate on COVID research with leading scientists. Find trustworthy information. Benefit from having access to your health data. …
Source: Hugo Health KindredCategories: Cardiologists, Latest HeadlinesTweet-
@Yale @YaleMed @YaleCII @PutrinoLab @WesElyMD @VirusesImmunity @yalediscovers @YaleSPH @NIH @_HealthMeasures @NIAIDNews @NatureMedicine The @Yale #PaxLCTrial will enroll from the @hugohealth @kindred_health network of people living with #longCOVID. These are people enabled w/their health data and interested in accelerating research. https://t.co/Q6Z7Qvb8DG https://t.co/5AqWJxwOJX
-
To see if eliminating such a viral reservoir could lead to recovery from #longCOVID, @hmkyale and a team of @YaleMed @YaleCII scientists have started #PaxLCTrial. Learn more about this trial here. (5/) https://t.co/5yCM3TLKnM